214 related articles for article (PubMed ID: 10025374)
1. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history.
Epstein BE; Pajak TF; Haulk TL; Herpst JM; Order SE; Abrams RA
Am J Clin Oncol; 1999 Feb; 22(1):22-8. PubMed ID: 10025374
[TBL] [Abstract][Full Text] [Related]
2. Fibrolamellar hepatoma.
Nagorney DM; Adson MA; Weiland LH; Knight CD; Smalley SR; Zinsmeister AR
Am J Surg; 1985 Jan; 149(1):113-9. PubMed ID: 2981486
[TBL] [Abstract][Full Text] [Related]
3. The histopathologic and clinical indicators of prognosis in hepatoma.
Chuong JJ; Livstone EM; Barwick KW
J Clin Gastroenterol; 1982 Dec; 4(6):547-52. PubMed ID: 6298304
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.
Kakar S; Burgart LJ; Batts KP; Garcia J; Jain D; Ferrell LD
Mod Pathol; 2005 Nov; 18(11):1417-23. PubMed ID: 15920538
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.
Chagas AL; Kikuchi L; Herman P; Alencar RS; Tani CM; Diniz MA; Pugliese V; Rocha Mde S; D'Albuquerque LA; Carrilho FJ; Alves VA
Clinics (Sao Paulo); 2015 Mar; 70(3):207-13. PubMed ID: 26017653
[TBL] [Abstract][Full Text] [Related]
6. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
McLarney JK; Rucker PT; Bender GN; Goodman ZD; Kashitani N; Ros PR
Radiographics; 1999; 19(2):453-71. PubMed ID: 10194790
[TBL] [Abstract][Full Text] [Related]
7. Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy.
Maniaci V; Davidson BR; Rolles K; Dhillon AP; Hackshaw A; Begent RH; Meyer T
Eur J Surg Oncol; 2009 Jun; 35(6):617-21. PubMed ID: 19144491
[TBL] [Abstract][Full Text] [Related]
8. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
Ward SC; Waxman S
Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
[TBL] [Abstract][Full Text] [Related]
9. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy.
Tanaka H; Hijioka S; Iwaya H; Mizuno N; Kuwahara T; Okuno N; Ito A; Kuraoka N; Matsumoto S; Obata M; Kurita Y; Yasuda M; Shimizu Y; Kuroda H; Sato Y; Haneda M; Sasaki E; Yatabe Y; Hara K
Intern Med; 2018 Dec; 57(24):3537-3543. PubMed ID: 30101933
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Ihde DC; Matthews MJ; Makuch RW; McIntire KR; Eddy JL; Seeff LB
Am J Med; 1985 Mar; 78(3):399-406. PubMed ID: 2579551
[TBL] [Abstract][Full Text] [Related]
11. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
12. Fibrolamellar hepatic carcinoma in an area with a low incidence of primary liver cancer: a retrospective study.
Kaczynski J; Gustavsson B; Hansson G; Wallerstedt S
Eur J Surg; 1996 May; 162(5):367-71. PubMed ID: 8781917
[TBL] [Abstract][Full Text] [Related]
13. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging.
Ichikawa T; Federle MP; Grazioli L; Marsh W
Radiology; 2000 Oct; 217(1):145-51. PubMed ID: 11012437
[TBL] [Abstract][Full Text] [Related]
14. Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management.
Stevens WR; Johnson CD; Stephens DH; Nagorney DM
AJR Am J Roentgenol; 1995 May; 164(5):1153-8. PubMed ID: 7717223
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients.
Ringe B; Pichlmayr R; Wittekind C; Tusch G
World J Surg; 1991; 15(2):270-85. PubMed ID: 1851588
[TBL] [Abstract][Full Text] [Related]
16. Successful multimodal treatment for aggressive metastatic and recurrent fibrolamellar hepatocellular carcinoma in a child.
Okur A; Eser EP; Yilmaz G; Dalgiç A; Akdemir ÜÖ; Oğuz A; Karadeniz C; Akyol G; Demiroğullari B; Boyunağa Ö; Pinarli FG
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e328-32. PubMed ID: 24608073
[TBL] [Abstract][Full Text] [Related]
17. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
18. [Fibrolamellar carcinoma of the liver: hepatocellular carcinoma with favourable prognosis].
Denis J; Grippon P; Legendre C; Tubiana JM; Lévy VG
Gastroenterol Clin Biol; 1984 Dec; 8(12):920-4. PubMed ID: 6097494
[TBL] [Abstract][Full Text] [Related]
19. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center.
Marcos-Alvarez A; Jenkins RL; Washburn WK; Lewis WD; Stuart KE; Gordon FD; Kane RA; Clouse ME
Arch Surg; 1996 Mar; 131(3):292-8. PubMed ID: 8611095
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: importance of histologic classification as a prognostic factor.
Wood WJ; Rawlings M; Evans H; Lim CN
Am J Surg; 1988 May; 155(5):663-6. PubMed ID: 2835911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
